March 13, 2017 / 11:48 AM / 4 months ago

BRIEF-Bellerophon Therapeutics reports Q4 loss per share of $0.37

1 Min Read

March 13 (Reuters) - Bellerophon Therapeutics Inc

* Bellerophon reports fourth quarter 2016 financial results and provides business update

* Q4 loss per share $0.37

* Enrollment continues in Inovation-1, with topline results targeted in mid-2018 and interim read expected around end of 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below